Sort   by:  
 Page size 
UnknownAssociations between Dietary Patterns, ADRβ2 Gln27Glu and ADRβ3 Trp64Arg with Regard to Serum Triglyceride Levels: J-MICC Study.
Not available
S-EPMC5037531 | biostudies-literature
UnknownSLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis.
Not available
S-EPMC10152287 | biostudies-literature
UnknownImpact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.
Not available
S-EPMC12819093 | biostudies-literature
UnknownSecretion of mitochondrial DNA via exosomes promotes inflammation in Behcet's syndrome.
Not available
S-EPMC10577637 | biostudies-literature
UnknownSecretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome
Not available
S-SCDT-10_15252-EMBJ_2022112573 | biostudies-other
UnknownEfficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Not available
S-EPMC3819942 | biostudies-literature
UnknownIdentification of close relatives in the HUGO Pan-Asian SNP database.
Not available
S-EPMC3248454 | biostudies-literature
UnknownClinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
Not available
S-EPMC7666431 | biostudies-literature
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
Sort   by:  
 Page size